Cointime

Alimera Sciences

company

About

Alimera Sciences is a biopharmaceutical company.

  • 51 - 100

Highlights

Total Funding Amount
$35M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Post-IPO Debt
Last Funding Money Raised
$35M
Industries
Biotechnology,Health Care,Medical
Founded date
Jan 1, 2003
Number Of Employee
51 - 100
Operating Status
Active

Alimera Sciences is a pharmaceutical company that specializes in the research, development, and commercialization of prescription ophthalmic pharmaceuticals. They are focused on diseases affecting the back of the eye, or retina because these diseases are not well treated with current therapies and will affect millions of people in their aging populations.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$35M
Alimera Sciences has raised a total of $35M in funding over 2 rounds. Their latest funding was raised on Apr 24, 2014 from a Post-IPO Debt round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 24, 2014 Post-IPO Debt $35M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
Alimera Sciences is funded by 1 investors. Hercules Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Hercules Capital — Post-IPO Debt
Cointime
เนื้อหา
บริษัท